The landscape of microbiome drug development is constantly evolving. The road to market is incredibly complex and it's vital to find the right strategic partners to bring products to patients.
Microbiome Connect: Europe is the sector's premier strategic event, enabling you to discover new innovative technologies and foster connections that will ensure your company's clinical and commercial success. Bringing together the whole microbiome therapeutics ecosystem - from investors and large pharmaceutical companies, through to the most pioneering biotechs, academic institutions and solution providers - it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth case studies and expanded networking opportunities.
Microbiome Connect: Europe is the sector's premier strategic event, enabling you to discover new innovative technologies and foster connections that will ensure your company's clinical and commercial success. Bringing together the whole microbiome therapeutics ecosystem - from investors and large pharmaceutical companies, through to the most pioneering biotechs, academic institutions and solution providers - it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth case studies and expanded networking opportunities.
